Wang XJ - Search Results

1

Role of Procalcitonin in Differentiating between Infectious and Noninfectious Fevers among Patients with Lymphoma.

Wang XJ, Tan TT, Lim ST, Farid M, Tao M, Quek R, Chan A, Tang T. Wang XJ, et al. Pharmacotherapy. 2017 Aug;37(8):908-915. doi: 10.1002/phar.1963. Epub 2017 Jul 18. Pharmacotherapy. 2017. PMID: 28556122

2

Costs associated with febrile neutropenia in solid tumor and lymphoma patients - an observational study in Singapore.

Wang XJ, Wong M, Hsu LY, Chan A. Wang XJ, et al. BMC Health Serv Res. 2014 Sep 24;14:434. doi: 10.1186/1472-6963-14-434. BMC Health Serv Res. 2014. PMID: 25252614 Free PMC article.

3

Economic burden of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.

Wang XJ, Lopez SE, Chan A. Wang XJ, et al. Crit Rev Oncol Hematol. 2015 May;94(2):201-12. doi: 10.1016/j.critrevonc.2014.12.011. Epub 2014 Dec 31. Crit Rev Oncol Hematol. 2015. PMID: 25600838 Review.

4

Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy.

Wang XJ, Tang T, Farid M, Quek R, Tao M, Lim ST, Wee HL, Chan A. Wang XJ, et al. PLoS One. 2016 Feb 12;11(2):e0148901. doi: 10.1371/journal.pone.0148901. eCollection 2016. PLoS One. 2016. PMID: 26871584 Free PMC article.

5

Psychometric Properties of the Functional Assessment of Cancer Therapy-Neutropenia in Asian Cancer Patients With Chemotherapy-Induced Neutropenia.

Wang XJ, Wong CM, Chan A. Wang XJ, et al. J Pain Symptom Manage. 2016 Sep;52(3):428-36. doi: 10.1016/j.jpainsymman.2016.03.016. Epub 2016 Jul 5. J Pain Symptom Manage. 2016. PMID: 27392885 Free article.

6

Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.

Wang XJ, Chan A. Wang XJ, et al. Curr Oncol Rep. 2017 Mar;19(3):20. doi: 10.1007/s11912-017-0578-5. Curr Oncol Rep. 2017. PMID: 28271398 Review.

7

The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas.

Wang XJ, Goh DYT, Dorajoo SR, Chan A. Wang XJ, et al. Support Care Cancer. 2017 Sep;25(9):2815-2822. doi: 10.1007/s00520-017-3696-6. Epub 2017 Apr 11. Support Care Cancer. 2017. PMID: 28401314

8

Therapeutic Use of Filgrastim for Established Febrile Neutropenia Is Cost Effective Among Patients With Solid Tumors and Lymphomas.

Wang XJ, Tong WX, Chan A. Wang XJ, et al. Clin Ther. 2017 Jun;39(6):1161-1170. doi: 10.1016/j.clinthera.2017.05.345. Epub 2017 May 26. Clin Ther. 2017. PMID: 28554533

9

Perceptions and Barriers of Survivorship Care in Asia: Perceptions From Asian Breast Cancer Survivors.

Chan A, Lum ZK, Ng T, Eyob T, Wang XJ, Chae JW, Dorajoo S, Shwe M, Gan YX, Fok R, Loh KW, Tan YP, Fan G. Chan A, et al. Among authors: wang xj. J Glob Oncol. 2016 Jun 8;3(2):98-104. doi: 10.1200/JGO.2016.004929. eCollection 2017 Apr. J Glob Oncol. 2016. PMID: 28717749 Free PMC article.

10

Minimal Clinically Important Difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for Fatigue Worsening in Asian Breast Cancer Patients.

Chan A, Yo TE, Wang XJ, Ng T, Chae JW, Yeo HL, Shwe M, Gan YX. Chan A, et al. Among authors: wang xj. J Pain Symptom Manage. 2018 Mar;55(3):992-997.e2. doi: 10.1016/j.jpainsymman.2017.10.014. Epub 2017 Oct 31. J Pain Symptom Manage. 2018. PMID: 29097274 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,442 results

Search Page

Filters